Edward Anderton is a postdoctoral researcher at the Buck Institute specializing in protein homeostasis and aging within the Lithgow Lab. He has contributed to venture development at Apollo Health Ventures and holds a Longevity Biotech Fellowship, highlighting his expertise in longevity biotech. Based in Novato, California, Anderton combines academic research with industry-focused experience in aging and longevity.

‌